Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

I-Mab and MorphoSys to Test C5aR1 Antibody in the US

Shanghai 's I-Mab and MorphoSys AG of Munich announced they have permission to start US trials of an anti-C5aR1 antibody in patients with advanced solid tumors. The candidate is designed to be used together with checkpoint inhibitors. Two years ago, I-Mab in-licensed greater China rights to the novel antibody in a $105 million agreement. As part of the deal, I-Mab agreed to conduct ex-China trials of the candidate in return for a single-digit royalty on sales outside of China . More details.... Stock Symbols: (NSDQ: IMAB) (FSE: MOR) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.